Correlation Between Cardio Diagnostics and Arvinas
Can any of the company-specific risk be diversified away by investing in both Cardio Diagnostics and Arvinas at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cardio Diagnostics and Arvinas into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cardio Diagnostics Holdings and Arvinas, you can compare the effects of market volatilities on Cardio Diagnostics and Arvinas and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cardio Diagnostics with a short position of Arvinas. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cardio Diagnostics and Arvinas.
Diversification Opportunities for Cardio Diagnostics and Arvinas
-0.8 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Cardio and Arvinas is -0.8. Overlapping area represents the amount of risk that can be diversified away by holding Cardio Diagnostics Holdings and Arvinas in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arvinas and Cardio Diagnostics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cardio Diagnostics Holdings are associated (or correlated) with Arvinas. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arvinas has no effect on the direction of Cardio Diagnostics i.e., Cardio Diagnostics and Arvinas go up and down completely randomly.
Pair Corralation between Cardio Diagnostics and Arvinas
Assuming the 90 days horizon Cardio Diagnostics Holdings is expected to generate 5.29 times more return on investment than Arvinas. However, Cardio Diagnostics is 5.29 times more volatile than Arvinas. It trades about 0.19 of its potential returns per unit of risk. Arvinas is currently generating about -0.08 per unit of risk. If you would invest 2.98 in Cardio Diagnostics Holdings on October 1, 2024 and sell it today you would earn a total of 6.76 from holding Cardio Diagnostics Holdings or generate 226.85% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Significant |
Accuracy | 95.24% |
Values | Daily Returns |
Cardio Diagnostics Holdings vs. Arvinas
Performance |
Timeline |
Cardio Diagnostics |
Arvinas |
Cardio Diagnostics and Arvinas Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Cardio Diagnostics and Arvinas
The main advantage of trading using opposite Cardio Diagnostics and Arvinas positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cardio Diagnostics position performs unexpectedly, Arvinas can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arvinas will offset losses from the drop in Arvinas' long position.Cardio Diagnostics vs. Cardio Diagnostics Holdings | Cardio Diagnostics vs. Revelation Biosciences | Cardio Diagnostics vs. LMF Acquisition Opportunities | Cardio Diagnostics vs. Ocean Biomedical |
Arvinas vs. C4 Therapeutics | Arvinas vs. Monte Rosa Therapeutics | Arvinas vs. Nurix Therapeutics | Arvinas vs. Foghorn Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Fundamental Analysis View fundamental data based on most recent published financial statements |